Italia markets closed

BMY Jun 2024 44.000 put

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,78000,0000 (0,00%)
Alla chiusura: 10:12AM EDT
Schermo intero
Chiusura precedente3,7800
Aperto3,7800
Denaro0,9400
Domanda4,0000
Prezzo d'esercizio44,00
Scadenza2024-06-07
Min-Max giorno3,7800 - 3,7800
Contratto - Min-MaxN/D
Volume1
Open Interest6
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri